BTAI logo

BioXcel Therapeutics (BTAI) Operating Profit

Annual Operating Profit

-$167.62 M
-$7.97 M-4.99%

December 31, 2023

Summary

Performance

1-Year Change

-4.99%

3-Year Change

-103.68%

5-Year Change

-739.69%

15-Year Change

-3594.49%

BTAI Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

10.73%
BTAI annual operating income is higher than 10.73% of companies in Healthcare sector

High & Low

All-time High

-$2.12 M

3-Year Low

-$167.62 M
BTAI annual operating income is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BTAI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 12, 2025
BTAI next annual earnings announcement is scheduled for Mar 12, 2025

OtherBTAIprofitabilitymetrics:

Annual Operating Margin

-12.15 K%
BTAI annual operating profit margin is -12.15 thousand%

Annual Revenue

$1.38 M
BTAI annual revenue is $1.38 million

Annual Net Income

-$179.05 M
BTAI annual net profit is -$179.05 million

Annual EPS

-$6.15
BTAI annual earnings per share is -$6.15

Quarterly Operating Profit

-$13.74 M
+$2.70 M+16.42%

September 30, 2024

Summary

Performance

3-Month Change

+16.42%

1-Year Change

+30.87%

3-Year Change

+48.75%

5-Year Change

-50.43%

BTAI Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.27%
BTAI quarterly operating income is higher than 31.27% of companies in Healthcare sector

High & Low

All-time High

-$529.00 K

3-Year Low

-$52.89 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BTAI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
BTAI next earnings announcement is scheduled for Mar 12, 2025

OtherBTAIprofitabilitymetrics:

Quarterly Operating Margin

-6420.56%
BTAI quarterly operating profit margin is -6420.56%

Quarterly Revenue

$214.00 K
BTAI quarterly revenue is $214.00 thousand

Quarterly Net Income

-$13.65 M
BTAI quarterly net profit is -$13.65 million

Quarterly EPS

-$0.32
BTAI quarterly earnings per share is -$0.32

TTM Operating Profit

-$74.22 M
+$30.39 M+29.05%

September 30, 2024

Summary

Performance

3-Month Change

+29.05%

1-Year Change

+55.72%

3-Year Change

+27.17%

5-Year Change

-120.88%

BTAI TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.91%
BTAI TTM operating income is higher than 25.91% of companies in Healthcare sector

High & Low

All-time High

-$529.00 K

3-Year Low

-$200.64 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BTAI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
BTAI next earnings announcement is scheduled for Mar 12, 2025

OtherBTAIprofitabilitymetrics:

Annual Operating Margin

-12.15 K%
BTAI annual operating profit margin is -12.15 thousand%

TTM Revenue

$2.28 M
BTAI TTM revenue is $2.28 million

TTM Net Income

-$71.00 M
BTAI TTM net profit is -$71.00 million

TTM EPS

-$2.16
BTAI TTM earnings per share is -$2.16

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$167.62 M
BTAI annual operating income is -$167.62 million

Annual Gross Profit

$120.00 K
BTAI annual gross profit is $120.00 thousand

Annual Operating Expenses

$167.74 M
BTAI annual total operating expenses is $167.74 million

BTAI Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.0%+30.9%+55.7%
3 y3 years-103.7%+48.8%+27.2%
5 y5 years-739.7%-50.4%-120.9%

BTAI Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-56.8%at lowat high+74.0%at high+63.0%
5 y5-year-398.9%at low-63.3%+74.0%-120.9%+63.0%
alltimeall time-7806.6%at low-2497.3%+74.0%<-9999.0%+63.0%

BioXcel Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.74 M(-16.4%)
-$74.22 M(-29.1%)
Jun 2024
-
-$16.44 M(-32.0%)
-$104.61 M(-25.6%)
Mar 2024
-
-$24.16 M(+21.6%)
-$140.59 M(-16.1%)
Dec 2023
-$167.62 M(+5.0%)
-$19.88 M(-55.0%)
-$167.62 M(-16.5%)
Sep 2023
-
-$44.13 M(-15.8%)
-$200.64 M(+2.6%)
Jun 2023
-
-$52.41 M(+2.4%)
-$195.50 M(+9.0%)
Mar 2023
-
-$51.20 M(-3.2%)
-$179.37 M(+12.4%)
Dec 2022
-$159.65 M(+49.3%)
-$52.89 M(+35.7%)
-$159.65 M(+20.1%)
Sep 2022
-
-$38.99 M(+7.4%)
-$132.89 M(+10.1%)
Jun 2022
-
-$36.29 M(+15.3%)
-$120.71 M(+7.7%)
Mar 2022
-
-$31.48 M(+20.5%)
-$112.04 M(+4.8%)
Dec 2021
-$106.94 M(+29.9%)
-$26.13 M(-2.5%)
-$106.94 M(+4.9%)
Sep 2021
-
-$26.81 M(-2.9%)
-$101.90 M(+2.0%)
Jun 2021
-
-$27.61 M(+4.7%)
-$99.86 M(+6.6%)
Mar 2021
-
-$26.38 M(+25.0%)
-$93.68 M(+13.8%)
Dec 2020
-$82.30 M
-$21.10 M(-14.8%)
-$82.30 M(+18.2%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$24.77 M(+15.5%)
-$69.61 M(+29.0%)
Jun 2020
-
-$21.43 M(+42.9%)
-$53.98 M(+31.1%)
Mar 2020
-
-$15.00 M(+78.2%)
-$41.18 M(+22.5%)
Dec 2019
-$33.60 M(+68.3%)
-$8.41 M(-7.9%)
-$33.60 M(+3.4%)
Sep 2019
-
-$9.13 M(+5.8%)
-$32.50 M(+14.1%)
Jun 2019
-
-$8.63 M(+16.4%)
-$28.49 M(+23.3%)
Mar 2019
-
-$7.42 M(+1.4%)
-$23.09 M(+15.7%)
Dec 2018
-$19.96 M(+340.0%)
-$7.31 M(+42.9%)
-$19.96 M(+31.5%)
Sep 2018
-
-$5.12 M(+57.8%)
-$15.18 M(+38.3%)
Jun 2018
-
-$3.24 M(-24.3%)
-$10.97 M(+32.3%)
Mar 2018
-
-$4.29 M(+69.7%)
-$8.29 M(+82.8%)
Dec 2017
-$4.54 M(+114.0%)
-$2.53 M(+175.5%)
-$4.54 M(+125.6%)
Sep 2017
-
-$917.00 K(+62.3%)
-$2.01 M(+83.8%)
Jun 2017
-
-$565.00 K(+6.8%)
-$1.09 M(+106.8%)
Mar 2017
-
-$529.00 K
-$529.00 K
Dec 2016
-$2.12 M
-
-

FAQ

  • What is BioXcel Therapeutics annual operating income?
  • What is the all time high annual operating profit for BioXcel Therapeutics?
  • What is BioXcel Therapeutics annual operating profit year-on-year change?
  • What is BioXcel Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for BioXcel Therapeutics?
  • What is BioXcel Therapeutics quarterly operating profit year-on-year change?
  • What is BioXcel Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for BioXcel Therapeutics?
  • What is BioXcel Therapeutics TTM operating profit year-on-year change?

What is BioXcel Therapeutics annual operating income?

The current annual operating profit of BTAI is -$167.62 M

What is the all time high annual operating profit for BioXcel Therapeutics?

BioXcel Therapeutics all-time high annual operating income is -$2.12 M

What is BioXcel Therapeutics annual operating profit year-on-year change?

Over the past year, BTAI annual operating income has changed by -$7.97 M (-4.99%)

What is BioXcel Therapeutics quarterly operating income?

The current quarterly operating profit of BTAI is -$13.74 M

What is the all time high quarterly operating profit for BioXcel Therapeutics?

BioXcel Therapeutics all-time high quarterly operating income is -$529.00 K

What is BioXcel Therapeutics quarterly operating profit year-on-year change?

Over the past year, BTAI quarterly operating income has changed by +$6.13 M (+30.87%)

What is BioXcel Therapeutics TTM operating income?

The current TTM operating profit of BTAI is -$74.22 M

What is the all time high TTM operating profit for BioXcel Therapeutics?

BioXcel Therapeutics all-time high TTM operating income is -$529.00 K

What is BioXcel Therapeutics TTM operating profit year-on-year change?

Over the past year, BTAI TTM operating income has changed by +$93.40 M (+55.72%)